"UPMC facilities and practices are operating normally. Given this rapidly evolving situation, patients should contact their doctor within 24 hours of any scheduled appointment for updates. For more, visit our website. If you believe you have been exposed to the coronavirus, whether you have symptoms or not, you should contact your doctor or use UPMC AnywhereCare to receive initial guidance. A virtual care visit from home limits the spread of infection. If needed, UPMC can guide you safely to the next care site. If you are experiencing a fever, cough, and trouble breathing, you should visit an emergency department in your community for immediate care."

During the past decade, UPMC Liver Cancer Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "UPMC Liver Cancer Center" are "Carcinoid Syndrome" (1 trials), "Carcinoma, Hepatocellular" (1 trials), "Hepatoma" (1 trials) and "Liver Cancer" (1 trials). Many other conditions were trialed in "UPMC Liver Cancer Center" in a lesser frequency.

Most popular intervention types in "UPMC Liver Cancer Center" are "Device" (1 trials), "Drug" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Lanreotide" (1 trials), "Placebo" (1 trials), "SIR-Spheres microspheres" (1 trials) and "yttrium Y 90 glass microspheres" (1 trials). Other intervention names were less common.

The vast majority of trials in "UPMC Liver Cancer Center" are 3 trials for "All" genders.

Currently, there are NaN active trials in "UPMC Liver Cancer Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in UPMC Liver Cancer Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in UPMC Liver Cancer Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".